# US 2024/0200083 A1 · Plasmid system without selectable markers and production method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200083 A1
- Document ID: US20240200083A1
- Status: Published application
- Kind: A1
- Application number: 18/286,880
- Filed: 2021-11-25
- Published: 2024-06-20
- Earliest claimed: 2021-04-16
- Assignees: Nanjing GenScript Biotech Co., Ltd.
- Applicants: Nanjing GenScript Biotech Co., Ltd.
- Inventors: Fan Zhou; Yifan Li; Lu Zhang; Hong Li
- Web page: https://patentgrep.com/patent/US20240200083A1

## CPC

- C12N 15/64: General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12Q 1/68: involving nucleic acids
- C12N 2800/30: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention provides a precursor plasmid for preparing a plasmid without selectable markers, including: 1) a replication original site; 2) a selectable marker gene; 3) a target gene or a cloning site for inserting the target gene; and 4) paired recombination sites. The paired recombination sites enable the precursor plasmid to perform self-recombination in the presence of recombinase to form a molecule of daughter plasmid and a molecule of circular double-stranded DNA. The daughter plasmid includes the replication original site and the cloning site or target gene. The circular double-stranded DNA includes the selectable marker gene. The present invention also provides a method for preparing a plasmid without selectable markers by using the precursor plasmid. The prepared plasmid without selectable markers can be used in the field of gene and cell therapy as a DNA delivery vector or a virus packaging plasmid vector to improve the safety of the plasmid.

## Claims

### Claim 1

A precursor plasmid, comprising:
1) a replication original site;
2) a selectable marker gene;
3) a target gene or a cloning site for inserting the target gene; and
4) paired recombination sites, wherein
the paired recombination sites enable the precursor plasmid to perform self-recombination in the presence of recombinase to form a molecule of daughter plasmid without the selectable marker gene and a molecule of circular double-stranded DNA;
the daughter plasmid comprises the replication original site and the target gene, or comprises the replication original site and the cloning site; and
the circular double-stranded DNA comprises the selectable marker gene.

### Claim 2 (depends on 1)

The precursor plasmid according to claim 1, wherein the sequences of the paired recombination sites are in the same direction.

### Claim 3 (depends on 1)

The precursor plasmid according to claim 1, wherein the replication original site is adjacent to the target gene or the cloning site, the paired recombination sites are respectively adjacent to upstream and downstream of the replication original site and the target gene, or the paired recombination sites are respectively adjacent to upstream and downstream of the replication original site and the cloning site.

### Claim 4 (depends on 1)

The precursor plasmid according to claim 1, wherein the paired recombination sites are selected from the loxP sequence in the same direction, the FRT sequence in the same direction, and the attB/attP sequence in the same direction.

### Claim 5 (depends on 4)

The precursor plasmid according to claim 4, wherein the paired recombination sites are the lox71 sequence and the lox66 sequence in the same direction.

### Claim 6 (depends on 1)

The precursor plasmid according to claim 1, wherein the replication original site is selected from a replication original site for the pUC, a replication original site for the pMB1 and derivatives thereof, a replication original site for the ColE1, and a replication original site for the R6Kγ.

### Claim 7 (depends on 6)

The precursor plasmid according to claim 6, wherein the replication original site comprises the following sequences: nucleotide sequences as set forth in SEQ ID NOs: 43-46 and nucleotide sequences that have at least 80% identity with the nucleotide sequences as set forth in SEQ ID NOs: 43-46 and can function as the replication origin.

### Claim 8 (depends on 1)

The precursor plasmid according to claim 1, further comprising one or more of the following sequences: a rop gene sequence, a coding sequence of endonuclease, and a coding sequence of plasmid replication accessory protein.

### Claim 9 (depends on 1)

The precursor plasmid according to claim 1, wherein the selectable marker gene is an antibiotic resistant gene.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The precursor plasmid according to claim 1, further comprising the coding gene of the recombinase.

### Claim 12 (depends on 11)

The precursor plasmid according to claim 11, wherein the precursor plasmid can express the recombinase under suitable conditions.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The precursor plasmid according to claim 1, comprising a nucleotide sequence as set forth in SEQ ID NO: 8, 34, 39-42, or 47 or a nucleotide sequence that has at least 80% identity with the nucleotide sequence as set forth in SEQ ID NO: 8, 34, 39-42, or 47.

### Claim 15

(canceled)

### Claim 16 (depends on 1)

A method for preparing a daughter plasmid without selectable marker gene, comprising:
1) introducing the precursor plasmid according to claim 1 into a host cell that can express or can help express the recombinase, and screening out host cells that express the selectable marker gene;
2) culturing the host cells screened out in step 1) to allow the recombinase to be expressed in the host cells, and culturing the host cells and screening out host cells that do not express the selectable marker gene; and
3) culturing the host cells screened out in step 2) and extracting plasmids to obtain the daughter plasmid.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the paired recombination sites are the loxP sequence in the same direction, and the recombinase is the Cre recombinase; the paired recombination sites are the FRT sequence in the same direction, and the recombinase is the Flp recombinase; or the paired recombination sites are the attB/attP sequence in the same direction, and the recombinase is the PhiC31 recombinase.

### Claim 18 (depends on 16)

The method according to claim 16, wherein the paired recombination sites are the lox71 sequence and the lox66 sequence in the same direction, and the recombinase is the Cre recombinase.

### Claim 19 (depends on 16)

The method according to claim 16, wherein the host cell comprises the coding gene of the recombinase in the genome thereof, or the host cell comprises an expression vector containing the coding gene of the recombinase.

### Claim 20 (depends on 16)

The method according to claim 16, wherein the precursor plasmid comprises the coding gene of the recombinase, and the precursor plasmid can express the recombinase in the host cell.

### Claim 21 (depends on 16)

The method according to claim 16, wherein the recombinase is inducibly expressed in the host cell.

### Claim 22 (depends on 19)

The method according to claim 19, wherein the expression vector comprises a conditionally induced loss-type plasmid replication element.

### Claim 23 (depends on 16)

The method according to claim 16, wherein the host cell is E. coli.

### Claim 24 (depends on 1)

A kit for preparing a daughter plasmid without selectable marker gene, comprising the precursor plasmid according to claim 1, and a host cell that can express or can help express the recombinase.

### Claim 25

(canceled)

### Claim 26 (depends on 24)

The kit according to claim 24, wherein the paired recombination sites are the loxP sequence in the same direction, and the recombinase is the Cre recombinase; the paired recombination sites are the FRT sequence in the same direction, and the recombinase is the Flp recombinase; or the paired recombination sites are the attB/attP sequence in the same direction, and the recombinase is the phiC31 recombinase.

### Claim 27 (depends on 24)

The kit according to claim 24, wherein the paired recombination sites are the lox71 sequence and the lox66 sequence in the same direction, and the recombinase is the Cre recombinase.

### Claim 28 (depends on 24)

The kit according to claim 24, wherein the host cell comprises the coding gene of the recombinase in the genome thereof, or the host cell comprises an expression vector containing the coding gene of the recombinase.

### Claim 29

(canceled)

### Claim 30 (depends on 28)

The kit according to claim 28, wherein the expression vector comprises a conditionally induced loss-type plasmid replication element.

### Claim 31 (depends on 24)

The kit according to claim 24, wherein the host cell is E. coli.

### Claim 32

(canceled)

### Claim 33

A daughter plasmid, comprising a replication original site and a target gene, wherein the daughter plasmid does not comprise an antibiotic resistant gene.

### Claim 34 (depends on 33)

The daughter plasmid according to claim 33, wherein the replication original site is selected from a replication original site for the pUC, a replication original site for the pMB1 and derivatives thereof, a replication original site for the ColE1, and a replication original site for the R6Kγ.

### Claim 35 (depends on 33)

The daughter plasmid according to claim 33, wherein the replication original site comprises the following sequences: nucleotide sequences as set forth in SEQ ID NOs: 43-46 and nucleotide sequences that have at least 80% identity with the nucleotide sequences as set forth in SEQ ID NOs: 43-46 and can function as the replication origin.

### Claim 36 (depends on 33)

The daughter plasmid according to claim 33, wherein the target gene comprises one or more of the following sequences: a promoter, a coding gene of an expressed protein, and a terminator.

### Claim 37 (depends on 33)

The daughter plasmid according to claim 33, being capable of replicating in a host cell.

### Claim 38 (depends on 37)

The daughter plasmid according to claim 37, being capable of replicating in the host cell under a cell culture condition without screening stress.

### Claim 39 (depends on 16)

A daughter plasmid obtained by the method according to claim 16.

### Claim 40 (depends on 33)

A host cell comprising the daughter plasmid according to claim 33, wherein the daughter plasmid can replicate in the host cell.

### Claim 41

(canceled)

### Claim 42 (depends on 40)

The host cell according to claim 40, enabling amplification of the daughter plasmid under a cell culture condition without screening stress.

### Claim 43 (depends on 33)

A composition, comprising the daughter plasmid according to claim 33, wherein the content of the daughter plasmid is at least 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99%, wherein a method for determining a content of the daughter plasmid in the composition is an NGS analysis method or a gel electrophoresis imaging analysis method.

### Claim at position 44

-46. (canceled)
